Class 12 · Human Health and Diseases

Recombinant Vaccines & Production — NEET Biology

📚 Practice Concept
📖 NCERT Source

Recombinant DNA technology has allowed the production of antigenic polypeptides of pathogen in bacteria or yeast. Vaccines produced using this approach allow large scale production and hence greater availability for immunisation, e.g., hepatitis B vaccine produced from yeast.

NCERT Biology · Class 12 · Chapter 7 · Paragraph 40
Practice This Concept
QuestionPractice Question

Which modern technology is used to produce large-scale recombinant vaccines?

📖 Solution & NCERT Explanation
View solution & NCERT explanation

Correct answer: C C Recombinant DNA technology

rDNA is used to produce antigenic polypeptides for vaccine production.

❓ Frequently Asked Questions
What does NCERT say about Recombinant DNA technology has?
Recombinant DNA technology has allowed the production of antigenic polypeptides of pathogen in bacteria or yeast. Vaccines produced using this approach allow large scale production and hence greater availability for immunisation, e.g., hepatitis B vaccine produced from yeast.
Has this concept appeared in NEET?
Practice this NCERT concept with questions on MedicNEET.
Which chapter is this from?
Human Health and Diseases, Class 12 NCERT Biology.

Through deep analysis of NEET and NTA, 88 of 90 questions from the NEET 2026 paper were matched straight from the MedicNEET Biology question bank.

88/90
of the NEET 2026 Biology paper matched from the MedicNEET question bank

MedicNEET's Biology question bank is built from the same NCERT lines NTA picks repeatedly. Not random MCQs — questions crafted exactly like NTA crafts them.

88 of 90 NEET 2026 Biology questions traced to MedicNEET14,000+ Biology questionsHindi + English
Free to start · Hindi + English · 22,000+ questions · NEET 2026 pattern
Related Concepts from Human Health and Diseases
📘Practice all 41 NEET PYQs from Human Health and Diseases🔍See full Human Health and Diseases PYQ Analysis